Di Minno, Giovanni, and Roberto Ravasio. “Cost-Effectiveness Analysis of Caplacizumab in the New Standard of Care for Immune Thrombotic Thrombocytopenic Purpura in Italy”. Global and Regional Health Technology Assessment 8, no. 1 (April 1, 2021): 43–52. Accessed December 4, 2024. https://journals.aboutscience.eu/index.php/grhta/article/view/2191.